Showing results (81-90 of 153) with videos related to
Sort By:
Pageof 16
Lancet (London, England)|September 19, 2003
L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomasMina Fogel, Paul Gutwein, Sabine Mechtersheimer, et al.Cancer Letters|July 11, 2006
Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastasesAnka Thies, Anke Berlin, Georg Brunner, et al.Journal for Immunotherapy of Cancer|August 14, 2020
IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanomaRebekka Weber, Zeno Riester, Laura Hüser, et al.International Journal of Cancer|December 2, 2017
Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-responseDaniel Reimer, Maximilian Boesch, Dominik Wolf, et al.International Journal of Oncology|January 5, 2006
Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomasChengwen Zhang, Alexander Marmé, Till Wenger, et al.Cancer Letters|December 20, 2002
L1 adhesion molecule (CD 171) in development and progression of human malignant melanomaMina Fogel, Sabine Mechtersheimer, Monica Huszar, et al.Oncology Reports|September 30, 2009
Expression and prognostic value of L1-CAM in breast cancerChristine Schröder, Udo Schumacher, Mina Fogel, et al.Oncotarget|April 28, 2017
TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cellsLeonie Ratz, Mark Laible, Lukasz A Kacprzyk, et al.Cancers|March 6, 2021
<i>miR-449a</i> Repression Leads to Enhanced NOTCH Signaling in <i>TMPRSS2:ERG</i> Fusion Positive Prostate Cancer CellsSimone Bauer, Leonie Ratz, Doreen Heckmann-Nötzel, et al.Gynecologic Oncology|May 24, 2011
Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavageAnne-Kathleen Rupp, Christian Rupp, Sascha Keller, et al.Pageof 16